Pazoo, Inc. Bundle
What is Pazoo, Inc.'s Business Trajectory?
Pazoo, Inc., founded in 2010 as IUCSS, Inc., initially aimed to build an integrated health and wellness platform. Its early vision included social networking, expert advice, and e-commerce for people and pets.
The company's path has seen significant shifts, moving away from its initial operational focus to its current status as a shell company actively pursuing new ventures.
Pazoo, Inc.'s history is a narrative of corporate evolution. From its inception, the company sought to establish a presence in the health and wellness sector, with early plans encompassing diverse revenue streams like advertising. A key aspect of its development involved exploring opportunities within health, wellness, and the medical cannabis industry, particularly in laboratory testing. For a deeper understanding of the external factors influencing its business, consider a Pazoo, Inc. PESTEL Analysis.
As of late 2024, Pazoo, Inc. trades under the ticker PZOO on the OTC Markets, with a market capitalization around $2.69 thousand. This reflects its current operational state as a shell entity actively seeking new business opportunities, a significant departure from its founding ambitions.
What is the Pazoo, Inc. Founding Story?
Pazoo, Inc. began its journey on November 16, 2010, initially incorporated in Nevada as IUCSS, Inc. The company officially adopted the name Pazoo, Inc. on May 9, 2011. Founder David M. Cunic established the company with a vision to offer health and wellness solutions for both people and pets.
The Genesis of Pazoo Inc
Pazoo Inc history traces back to its incorporation in Nevada in late 2010. The company's founder, David M. Cunic, aimed to create a platform integrating social networking, research, expert resources, and e-commerce for health and wellness products.
- Incorporated in Nevada on November 16, 2010, as IUCSS, Inc.
- Name changed to Pazoo, Inc. on May 9, 2011.
- Founder David M. Cunic envisioned a health and wellness solutions company.
- Initial business model combined social networking, research, expert directories, and e-commerce.
The Pazoo company background reveals an early focus on health supplements, launching products like the MAXPLUS multivitamin and CELLMAX stem cell nutrition concentrate. Future product plans in early 2013 included a water oxygenator and anti-aging products. The company secured crucial seed capital in June 2012, receiving its first $250,000 investment as part of a larger $1,000,000 commitment from Integrated Capital Partners, Inc. (ICPI). This funding was instrumental for its initial operations and marketing endeavors. The principal executive offices were initially situated in Whippany, New Jersey, before relocating to East Hanover, New Jersey.
The Pazoo Inc founding story highlights a strategic approach to market entry, aiming to capture a segment of the growing health and wellness industry. The early years of Pazoo Inc were marked by the development of its foundational product line and the establishment of its corporate infrastructure. Understanding the Marketing Strategy of Pazoo, Inc. provides further insight into their initial market penetration efforts.
Pazoo, Inc. SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Pazoo, Inc.?
In its early years, Pazoo, Inc. focused on developing its health and wellness platform, Pazoo.com, with an initial strategy to generate revenue through advertising and direct product sales. The company introduced its first products, including a multivitamin and a stem cell nutrition concentrate, with plans for further development.
Initial Platform Development and Product Launch
Pazoo, Inc. initially concentrated on building its health and wellness online platform, Pazoo.com. The company launched its first product lines, MAXPLUS multivitamin and CELLMAX stem cell nutrition concentrate, with further product expansion anticipated in 2013.
Marketing Push and Operational Challenges
A significant marketing and advertising campaign was initiated in November 2013 to drive website traffic, with the expectation of increased advertising revenue. However, the company encountered operational hurdles, including website issues that had previously interrupted a smaller marketing effort.
Strategic Business Model Pivot
Pazoo, Inc. strategically shifted its business focus towards the health, wellness, and medical cannabis sectors. This pivot involved specializing in laboratory testing of cannabis and cannabinoids to ensure consumer safety from impurities, a significant departure from its earlier e-commerce and social networking model.
Financial Snapshot (Late 2017)
By the end of 2017, the company's primary operational focus was on cannabis testing. Financial data for the trailing twelve months ending December 31, 2017, showed null revenue, negative EBITDA of ($2,166) thousand, and a net income of ($3,545) thousand. Total assets were $129 thousand, with total debt at $3,120 thousand.
Pazoo, Inc. PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Pazoo, Inc. history?
Pazoo, Inc.'s history is a narrative of strategic shifts and operational hurdles. The company's rebranding from IUCSS, Inc. to Pazoo, Inc. in 2011 marked a significant step in establishing its corporate identity. Its early ventures focused on an integrated health and wellness platform, including the development of proprietary nutritional supplements. A key evolution in its business model involved entering the medical cannabis sector, specifically offering laboratory testing services to ensure product safety and compliance with industry standards. The company's most recent reported acquisition or merger was with MA & Associates on June 3, 2015.
| Year | Milestone |
|---|---|
| 2011 | Reincorporated and changed its name from IUCSS, Inc. to Pazoo, Inc., establishing its brand identity. |
| Early Years | Launched an integrated health and wellness platform and developed proprietary nutritional supplements like MAXPLUS and CELLMAX. |
| Strategic Shift | Transitioned focus to the medical cannabis industry, emphasizing laboratory testing services for product safety. |
| 2015 | Completed an acquisition or merger deal with MA & Associates on June 3. |
| 2016 | Underwent a 100:1 reverse stock split on March 30. |
Pazoo, Inc. introduced innovations through its integrated health and wellness platform and the development of proprietary nutritional supplements, aiming to cater to consumer health needs. The company also innovated by entering the medical cannabis space with a focus on laboratory testing, addressing the growing demand for product safety and quality assurance in a nascent industry.
Integrated Health Platform
Developed a comprehensive platform focused on health and wellness, integrating various services and products to support consumer well-being.
Proprietary Supplements
Created and launched its own line of nutritional supplements, such as MAXPLUS and CELLMAX, to offer specialized health solutions.
Medical Cannabis Testing
Pioneered laboratory testing services within the medical cannabis industry, ensuring product safety and compliance with regulatory standards.
The company faced significant challenges, including an SEC filing in October 2015 that indicated substantial doubt about its ability to continue as a going concern. This period also saw a change in its independent registered public accounting firm, moving from Malone Bailey, LLP to Friedman LLP, in an effort to enhance audit efficiency and ensure timely financial reporting. As of 2025, Pazoo, Inc. has underperformed relative to the US Interactive Media and Services industry's 32.9% return and the broader US Market's 20.2% return over the past year.
Going Concern Doubt
An October 2015 SEC filing highlighted conditions that raised substantial doubt about the company's ability to continue as a going concern, indicating financial instability.
Accounting Firm Change
The company changed its independent registered public accounting firm to Friedman LLP from Malone Bailey, LLP, aiming to improve audit efficiency and timely financial report filings.
Stock Performance Lag
In 2025, Pazoo, Inc. demonstrated underperformance when compared to the US Interactive Media and Services industry and the overall US Market, reflecting market challenges.
Reverse Stock Split
A 100:1 reverse stock split was executed on March 30, 2016, a common measure taken by companies facing low stock prices or seeking to meet exchange listing requirements.
Asset Divestiture
The company eventually divested its operational assets, transitioning into a shell company, signaling a need for significant restructuring and a new strategic direction to address past difficulties.
Pazoo, Inc. Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Pazoo, Inc.?
Pazoo, Inc. has a history marked by incorporation, name changes, investment, marketing efforts, a merger, accounting firm changes, a stock split, and a shift in operational focus. The company's journey reflects a dynamic business development path.
| Year | Key Event |
|---|---|
| 2010 | Incorporated in Nevada as IUCSS, Inc. on November 16. |
| 2011 | Name officially changed to Pazoo, Inc. on May 9. |
| 2012 | Secured its first $250,000 investment as part of a larger $1,000,000 commitment on June 11. |
| 2013 | Launched a significant marketing and advertising campaign for Pazoo.com on November 21. |
| 2015 | Completed a merger/acquisition with MA & Associates on June 3 and changed its independent registered public accounting firm to Friedman LLP on October 13. |
| 2016 | Effectuated a 100:1 reverse stock split of its common stock on March 30. |
| 2017 | The company's primary focus shifted to laboratory testing of cannabis and cannabinoids. |
| 2024 | Pazoo Inc. stock price was recorded at $0.0000 on September 23. |
| 2025 | On August 12, Pazoo, Inc. stock price reached $0.0001, showing a 900% gain over two weeks, though a double top formation indicated a sell signal. |
Current Status as a Shell Company
Pazoo, Inc. currently operates as a shell company, having divested its previous operational assets. Its future hinges on identifying and successfully implementing new business ventures.
Stock Performance and Market Presence
The company's stock, PZOO, trades on the OTC Markets with a very low market capitalization, approximately $2.69 thousand as of late 2024. Shares are noted as highly illiquid.
Future Strategic Direction
While specific future initiatives are not publicly detailed, the company's continued listing suggests an intent to re-enter a market. This aligns with its founding vision of pursuing opportunities in the health and wellness sector.
Pazoo Inc. Evolution and Outlook
The Brief History of Pazoo, Inc. highlights significant changes in its business model. The company's ongoing existence points to a potential pivot, seeking new avenues for growth within its original sphere of interest.
Pazoo, Inc. Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of Pazoo, Inc. Company?
- What is Growth Strategy and Future Prospects of Pazoo, Inc. Company?
- How Does Pazoo, Inc. Company Work?
- What is Sales and Marketing Strategy of Pazoo, Inc. Company?
- What are Mission Vision & Core Values of Pazoo, Inc. Company?
- Who Owns Pazoo, Inc. Company?
- What is Customer Demographics and Target Market of Pazoo, Inc. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.